SAP_Signed.pdf (1.12 MB)
Statistical analysis plan for Frontline treatment of Follicular Lymphoma with AtezolizUmab and Obinutuzumab with and without radiotherapy
Statistical analysis plan for Frontline treatment of Follicular Lymphoma with AtezolizUmab and Obinutuzumab with and without radiotherapy